We are proud to announce a new partnership with a Swedish hospital, paving the way for transformative advancements in personalised cancer care. This collaboration empowers hospital laboratories to implement efficient tumour-informed circulating tumour DNA (ctDNA) analysis with ease, precision, and minimal disruption to existing operations.
Are you also seeking to upgrade your laboratory’s cancer monitoring capabilities while streamlining operations and reducing costs? Discover how you and Simsen Diagnostics can enable your team to deliver personalised ctDNA analysis with confidence.
This solution is applicable to all hospital laboratories with access to a sequencer.
Personalised Panels – No In-House Development Required
- No need to develop your own tumour-informed panels: We design and supply patient-specific panels, enabling your lab to focus on high-quality ctDNA analysis.
- Accelerate time to implementation: Skip lengthy development phases and start offering advanced monitoring faster.
Seamless Integration with Your Workflow
- Sequencing-only solution: If you have a sequencer, you’re ready to go. No major capital investments.
- Minimal workflow disruption: Our protocols fit into your current lab infrastructure and clinical routines.
Knowledge Transfer and Support
- Expert protocol transfer: Your team receives hands-on knowledge and the latest ctDNA analysis methodologies from Simsen Diagnostics.
- Support: Ongoing guidance ensures your lab operates at the highest standards of sensitivity and accuracy.
Fully Integrated Solutions
- Comprehensive reagent kits: All necessary reagents supplied for a robust workflow.
- Sample collection kits available: For both tumour biopsies and plasma, simplifying logistics for your team.
Flexibility for Laboratory-Developed Tests (LDTs)
- Retain control: Use Simsen’s technology to develop your own LDTs, tailored to your patient population and institutional protocols.
Key Benefits for Hospital Laboratory Managers
- Seamless adoption: Integrate with your current sequencing platform. No new hardware required.
- Save time and resources: Avoid costly and time-consuming panel development and validation.
- Stay ahead of the curve: Access the latest protocols and scientific advances in ctDNA detection.
- Boost operational efficiency: Unified supply of panels, reagents, and collection kits.
- Enhance clinical impact: Provide clinicians and patients with earlier, more accurate detection of the tumour burden.
- Strengthen your lab’s reputation: Position your laboratory as a leader in precision oncology, with personalised ctDNA analysis.
Join the Future of Cancer Monitoring
This partnership is just the first step. At Simsen Diagnostics, we empower hospital laboratories to deliver world-class, personalised cancer care, without compromise.
Ready to transform your cancer monitoring program?
Contact us today to learn how Simsen Diagnostics can help your laboratory become a leader in precision cancer monitoring. Send an email to inbox@simsendiagnostics.com to discover how we can work together to save you time and money, and enhance your laboratory services.
Simsen Diagnostics – Personalised assays, personalised service.
